This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Eutilex Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sun-Woo Im: Innovator in CAR-T Cell Therapy
Introduction
Sun-Woo Im is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunotherapy, particularly in CAR-T cell therapy. His innovative work has the potential to transform cancer treatment and improve patient outcomes.
Latest Patents
Sun-Woo Im holds a patent for "GPC3 CAR-T Cell Compositions and Methods of Making and Using the Same." This patent represents a crucial advancement in the development of targeted therapies for cancer treatment. With 1 patent to his name, he is recognized for his pioneering efforts in this specialized area of research.
Career Highlights
Im is currently associated with Eutilex Co., Ltd., a company dedicated to advancing cancer therapies. His role at Eutilex allows him to collaborate with other experts in the field and contribute to groundbreaking research. His work is instrumental in the ongoing development of innovative treatments that harness the power of the immune system.
Collaborations
Sun-Woo Im has worked alongside notable colleagues, including Byoung S Kwon and Kwanghee Kim. These collaborations have fostered a dynamic research environment, enabling the team to push the boundaries of current cancer therapies.
Conclusion
Sun-Woo Im is a key figure in the field of CAR-T cell therapy, with a focus on innovative solutions for cancer treatment. His contributions and collaborations continue to pave the way for advancements in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile